Industry News

The excitement and growth potential of deuterated pharmaceuticals is going main-stream as reported in the Economist magazine in their Medical Chemistry section (see link below). With the emphasis being “Drugs… Continue reading →

First Auspex Pharmaceuticals announces its IPO priced at $12.00 per share, and now Concert Pharmaceuticals announces its IPO at $14.00 per share.  Auspex and Concert are both working on developing… Continue reading →

Auspex Pharmaceuticals Inc has raised $35 million which will advance the clinical trials of its deuterium substituted drug SD-809 designed for the treatment of chorea associated with Huntington’s disease.  In… Continue reading →

The growing use of deuterium in the high tech sector has again been demonstrated. In a news release by PR Newswire, Toshiba has announced a major breakthrough in the fabrication… Continue reading →

This article is one of an ‘Expert Tips’ series from Waters, and it has useful recommendations for deuterium labelling of peptides for protein structural dynamics and conformational changes.  Deuterium oxide… Continue reading →

Here is an interesting link about Samsung’s activities to make a better microchip through use of deuterium (heavy hydrogen).  The core technology was discovered at the University of Illinois University… Continue reading →

One of the many examples of innovation based on deuterium’s role in non-radioactive life science applications is with living cells.  A technique uses the fact a carbon-deuterium bond vibrates at… Continue reading →